Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli

Applied Microbiology and Biotechnology

Volumn 95, Issue 4, 2012, Pages 939-945

  Lu, X ^a,b   Shen, J ^a,b   Jin, X ^a   Ma, Y ^a,b   Huang, Y ^a   Mei, H ^a   Chu, F ^a,b   Zhu, J ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Flow cytometry. Transmission electron; Lipopolysaccharide; Multidrug resistant; Musca domestica cecropin

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BACTERICIDAL ACTIVITY; BACTERICIDAL AGENT; CECROPIN; CLINICAL ISOLATES; CYTOTOXIC EFFECTS; DNA BINDING; E. COLI; GRAM-NEGATIVE BACTERIA; HUMAN RED BLOOD CELL; INNER MEMBRANES; LIPOPOLYSACCHARIDES; MEMBRANE PERMEABILIZATION; MINIMAL INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT; MUSCA DOMESTICA; PROPIDIUM; STANDARD STRAIN; TRANSMISSION ELECTRON; TRANSMISSION ELECTRON MICROGRAPH;

BACTERIA; BACTERICIDES; CLONING; CYTOTOXICITY; FLOW CYTOMETRY; GENES;

ESCHERICHIA COLI;

CECROPIN; LIPOPOLYSACCHARIDE; PROPIDIUM IODIDE;

ANTIMICROBIAL ACTIVITY; BACTERIUM; COLIFORM BACTERIUM; DRUG RESISTANCE; FLOW CYTOMETRY; FLY; INHIBITOR; INSECTICIDE; MEMBRANE; MICROBIAL ACTIVITY; PEPTIDE; POLYSACCHARIDE; TOXICITY;

ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; ERYTHROCYTE; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE TARGETING; HEMOLYSIS; HOUSE FLY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; OUTER MEMBRANE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CECROPINS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; FLOW CYTOMETRY; HEMOLYSIS; HOUSEFLIES; LARVA; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION;

ESCHERICHIA COLI; MUSCA DOMESTICA; NEGIBACTERIA; POSIBACTERIA;

EID: 84864623607     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3793-2     Document Type: Article

References (20)

1. Arcidiacono S, Soares JW, Meehan AM, Marek P, Kirby R (2009) Membrane permeability and antimicrobial kinetics of cecropin P1 against Escherichia coli. J Pept Sci 15(6):398-403
2. Ashour HM, El-Sharif A (2009) Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med 7:14
3. Bodmann KF (2005) Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy 51(5):227-233
4. Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250
5. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM (2010) Antimicrobial peptides: General overview and clinical implications in human health and disease. Clin Immunol 135 (1):1-11
6. Guerreiro CI, Fontes CM, Gama M, Domingues L (2008) Escherichia coli expression and purification of four antimicrobial peptides fused to a family 3 carbohydrate-binding module (CBM) from Clostridium thermocellum. Protein Expr Purif 59(1):161-168
7. Hammer MU, Brauser A, Olak C, Brezesinski G, Goldmann T, Gutsmann T, Andra J (2010) Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis. Biochem J 427:477-488
8. Hou L, Shi Y, Zhai P, Le G (2007) Antibacterial activity and in vitro anti-Tumor activity of the extract of the larvae of the housefly (Musca domestica). J Ethnopharmacol 111(2):227-231
9. Huang L, Leong SS, Jiang R (2009) Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27. Appl Microbiol Biotechnol 84:301-308
10. King JD, Kocincova D, Westman EL, Lam JS (2009) Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun 15(5):261-312
11. Kuntaman K, Lestari ES, Severin JA, Kershof IM, Mertaniasih NM, Purwanta M, Hadi U, Johnson JR, van Belkum A, Verbrugh HA (2005) Fluoroquinolone- resistant Escherichia coli, Indonesia. Emerg Infect Dis 11(9):1363-1369
12. Lim KT, Yasin R, Yeo CC, Puthucheary S, Thong KL (2009) Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J Biomed Biotechnol 2009:165637
13. Lu XM, Jin XB, Zhu JY, Mei HF, Ma Y, Chu FJ, Wang Y, Li XB (2010) Expression of the antimicrobial peptide cecropin fused with human lysozyme in Escherichia coli. Appl Microbiol Biotechnol 87:2169-2176
14. Mihajlovic M, Lazaridis T (2010) Antimicrobial peptides bind more strongly to membrane pores. Biochim Biophys Acta 1798(8):1494-1502
15. Papo N, Shai Y (2005) A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. J Biol Chem 280:10378-10387
16. Schmitt P, Mercado L, Diaz M, Guzman F, Arenas G, Marshall SH (2008) Characterization and functional recovery of a novel antimicrobial peptide (CECdir-CECret) from inclusion bodies after expression in Escherichia coli. Peptides 29(4):512-519
17. Song YM, Park Y, Lim SS, Yang ST,Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY (2005) Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 44:12094-12106
18. Song S, Lee EY, Koh EM, Ha HS, Jeong HJ, Bae IK, Jeong SH (2009) Antibiotic resistance mechanisms of Escherichia coli Isolates from urinary specimens. Korean J Lab Med 29(1):17-24
19. Strauss J, Kadilak A, Cronin C, Mello CM, Camesano TA (2010) Binding, inactivation, and adhesion forces between antimicrobial peptide cecropin P1 and pathogenic E. coli. Colloids Surf B Biointerfaces 75(1):156-164
20. Wu G, Fan X, Li L,Wang H, Ding J, HongbinW, Zhao R, Gou L, Shen Z, Xi T (2009) Interaction of antimicrobial peptide s-Thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli. Int J Antimicrob Agents 35(3):250-254